U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07612436) titled 'AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)' on May 21.
Brief Summary: Colorectal cancer (CRC) ranks third in both incidence and mortality among all malignant tumors in China. Studies have shown that early screening can significantly reduce its incidence and mortality. Colonoscopy is the gold standard for CRC screening; however, compliance with colonoscopy among high-risk groups in China is very low. Artificial intelligence (AI)-assisted tools can provide real-time, personalized health education, and nudge strategies can help translate intent into action. This trial aims to evaluate the effectiveness of AI-empowered nudge...